Abstract Commentary: Association Between Patient-Reported Outcomes and Changes in Prostate-Specific Antigen in Patients with Advanced Prostate Cancer Treated with Apalutamide in the Spartan and Titan Studies

Benjamin H. Lowentritt, MD, FACS, presented this lecture during the 32nd Annual International Prostate Cancer Update on March 8, 2022, in Snowbird, Utah.

Read More